Sponsored Seminar

Luncheon Seminar Program

September 30th (Thu)

L Live, O On-demand

LS1 Eli Lilly Japan K.K.L

September 30th (Thu) 11:50~12:40(Second venue)PACIFICO Yokohama 3rd floor Room 301
Chair:Katsuyuki Kiura(Department of Allergy and Respiratory Medicine, Okayama University Hospital)
Treatment strategies for diversified driver gene mutation positive NSCLC・Diagnostic aspects
Speaker 1:Kengo Takeuchi(Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research)
Treatment strategies for diversified driver gene mutation positive NSCLC・Clinical aspects
Speaker 2:Makoto Nishio(Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research)

LS2 Nippon Becton Dickinson Company, Ltd. L O

September 30th (Thu) 11:50~12:40(Third venue)PACIFICO Yokohama 3rd floor Room 302
Chair:Takuya Yamamoto(National Institutes of Biomedical Innovation, Health and Nutrition, Laboratory of Immunosenescence)
“Bedside to Bench and Back” – The Innovative Cancer Immunological Research by the High-Dimensional Single-Cell Analysis of Surgical Resected Samples
Speaker:Hirofumi Akita(Department of Gastroenterological Surgery, Osaka International Cancer Institute)

LS3 SymBio Pharmaceuticals, Ltd.

September 30th (Thu) 11:50~12:40(4th venue)PACIFICO Yokohama 3rd floor Room 303
Chair:Akifumi Takaori(Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University)
Treatment strategies for relapsed or refractory diffuse large B-cell lymphoma
Speaker:Itaru Matsumura(Department of Hematology and Rheumatology, Kindai University Faculty of Medicine)

LS4 Scrum Inc.L O

September 30th (Thu) 11:50~12:40(5th venue)PACIFICO Yokohama 3rd floor Room 304
Chair:Tomoshi Kakeya(Scrum Inc.)
Assay Solutions for Confident Decision Making in Targeted Therapeutics Development
~ From high-throughput signaling protein expression analysis to immuno-cell killing assay~
Speaker:Toru Hattori(Strategic Marketing Division, Scrum Inc.)

LS5 Novocure Ltd.O

September 30th (Thu) 11:50~12:40(7th venue)PACIFICO Yokohama 3rd floor Room 311+312
Chair:Hideo Nakamura(Department of Neurosurgery, Kurume University Hospital)
Tumor Treating Fields : from the Petri dish to the Patient
Speaker:Moshe Giladi(Senior Director of Preclinical, Novocure Ltd)

LS6 AstraZeneca K.K.

September 30th (Thu) 11:50~12:40(8th venue)PACIFICO Yokohama 3rd floor Room 313+314
Chair:Hideaki Miyake(Department of Urology, Hamamatsu University School of Medicine)
Cancer Precision Medicine in Prostate Cancer
Speaker:Shusuke Akamatsu(Department of Urology, Kyoto University Graduate School of Medicine)

LS7 Eisai Co., Ltd.L

September 30th (Thu) 11:50~12:40(9th venue)PACIFICO Yokohama 4rd floor Room 411+412
Chair:Koichi Akashi(Department of Medicine and Biosystemic Science, Graduate School of Medical Science, Kyushu University)
Epigenetic abnormalities in B-cell lymphoma
Speaker:Momoko Nishikori(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

LS8 Leica Microsystems K.K.

September 30th (Thu) 11:50~12:40(11th venue)PACIFICO Yokohama 4rd floor Room 414+415
Chair:Shintaro Tanaka(Leica Microsystems K.K., LSR Division)
Proteogenomics Analysis with LMD for Oncology
Speaker 1:Nobuhide Tsurumaki(Leica Microsystems K.K., LSR Division)
Cell DIVE Multiplex Imaging Solution for Precision Oncology
Speaker 2:Toshiyuki Hatano(Leica Microsystems K.K., LSR Division)

LS9 TAIHO PHARMACEUTICAL CO., LTD.

September 30th (Thu) 11:50~12:40(12th venue)PACIFICO Yokohama 4rd floor Room 416+417
Chair:Yukio Hosomi(Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan)
Lung cancer chemotherapy updates
Speaker:Hiroyuki Yasuda(Division of Pulmonary Medicine, Keio University, School of Medicine)

LS10 Novartis Pharma K.K. L

September 30th (Thu) 11:50~12:40(13th venue)PACIFICO Yokohama 4rd floor Room 418
Chair:Keisuke Kataoka(Division of Hematology, Department of Medicine, Keio University School of Medicine)
Clinical practice in CAR-T cell therapy
Speaker:Jun Kato(Division of Hematology, Department of Medicine, Keio University School of Medicine)

LS11 Invitae Japan K.K.O

September 30th (Thu) 11:50~12:40(15th venue)PACIFICO Yokohama 5rd floor Room 501
Chair:Nahoko Sakai(Invitae Japan K.K.)
Invitae Liquid Biopsy Solutions: LiquidPlex and Personalized Cancer Monitoring (PCM)
Speaker:Vishal Sikri(Invitae corporation)

October 1st (Fri)

LS12 Takeda Pharmaceutical Co., Ltd.L

October 1st (Fri) 11:50~12:40(First venue)PACIFICO Yokohama 1th floor Main hall
Chair:Hirotsugu Uemura(Department of Urology, Kindai University Faculty of Medicine)
Optimal therapeutic strategy for advanced renal cell carcinoma in the era of combined immunotherapy
Speaker:Hideaki Miyake(Department of Urology, Hamamatsu University School of Medicine)

LS13 Otsuka Pharmaceutical Co., Ltd. L

October 1st (Fri) 11:50~12:40(Second venue)PACIFICO Yokohama 3rd floor Room 301
Chair:Hideaki Nakajima(Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine)
Current status and future prospects of the cancer immunotherapy; focus on the relationship between cancer cells and immune cells
Speaker:Hiroyoshi Nishikawa(Division of Cancer Immunology, Research Institute/ Exploratory Oncology Research & Clinical Trial Center National Cancer Center)

LS14Illumina K.K. O

October 1st (Fri) 11:50~12:40(Third venue)PACIFICO Yokohama 3rd floor Room 302
Chair:Hideki Hanaoka(Regional Segment Marketing Department, Asia Pacific and Japan, Illumina)
Revolution in Cancer Genomic Medicine
Speaker:Yusuke Nakamura(Cancer Precision Medicine Center, Japanese Foundation for Cancer Research)

LS15Chugai Pharmaceutical Co., Ltd.L

October 1st (Fri) 11:50~12:40(4th venue)PACIFICO Yokohama 3rd floor Room 303
Chair:Eishi Baba(Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University)
How to utilize comprehensive genomic profiling test for daily clinical practice
Speaker:Masashi Kanai(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)

LS16Mitsubishi Space Software Co., Ltd. O

October 1st (Fri) 11:50~12:40(5th venue)PACIFICO Yokohama 3rd floor Room 304
Chair:Mototsugu Oya(Department of Urology, Keio University School of Medicine)
PleSSision-Rapid; a cancer genomic screening test promote precision cancer medicine in Keio University Hospital
Speaker:Hiroshi Nishihara(Genomics Unit, Keio Cancer Center, Keio University School of Medicine)

LS17 DAIICHI SANKYO COMPANY, LIMITED.L

October 1st (Fri) 11:50~12:40(7th venue)PACIFICO Yokohama 3rd floor Room 311+312
Chair:Yasuo Hamamoto(Keio University School of Medicine)
Providing optimal treatment for cancer eradication: Focusing on total care including cancer pain treatment
Speaker:Taroh Satoh(Frontier Sci. for Cancer & Chemother, Osaka University Graduate School of Medicine)

LS18Novartis Pharma K.K.L

October 1st (Fri) 11:50~12:40(8th venue)PACIFICO Yokohama 3rd floor Room 313+314
Chair:Toshinari Yamashita(Department of Breast and Endocrine Surgery, Kanagawa Cancer Center)
Future Direction of Translational Research in Optimizing Breast Cancer Treatment Strategy
Speaker:Yoichi Naito(Department of Medical Oncology, National Cancer Center Hospital East)

LS19AbbVie GK L

October 1st (Fri) 11:50~12:40(9th venue)PACIFICO Yokohama 4rd floor Room 411+412
Chair:Koichi Akashi(Kyushu University)
Molecular Diagnosis and Target Therapy for Acute Myeloid Leukemia
Speaker:Yamaguchi Hiroki(Nippon Medical School)

LS20 Nikon Corporation. O

October 1st (Fri) 11:50~12:40(11th venue)PACIFICO Yokohama 4rd floor Room 414+415
Chair:Yasujiro Kiyota (Nikon Corporation)
Advanced T Cell Analytics Using Digital Cell Biology at Light Speed
Speaker:Tina Kang(Berkeley Lights Inc.,)

LS21 MSD K. K. L

October 1st (Fri) 11:50~12:40(12th venue)PACIFICO Yokohama 4rd floor Room 416+417
Chair:Hisashi Wada(Osaka University, Clinical Research in Tumor Immunology)
Targeting "a Triple Low" in the tumor microenvironment
Speaker:Heiichiro Udono(Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences)

LS22 SBI Pharmaceuticals Co., Ltd. O

October 1st (Fri) 11:50~12:40(13th venue)PACIFICO Yokohama 4rd floor Room 418
Chair:Kenji Chamoto(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
Cancer immunotherapy based on immune checkpoint inhibitors and mitochondrial regulation drugs
Speaker 1:Kenji Chamoto(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
5-ALA/SFC enhanced effect of immune checkpoint inhibitor
Speaker 2:Xiao-Kang Li(Division of Transplantation Immunology, National Research Institute for Child Health and Development)
NK cell activation by 5-aminolevulinic acid
Speaker 3:Motowo Nakajima(Division of Development, SBI Pharmaceuticals Co., Ltd.)

LS23 Nippon Boehringer Ingelheim Co., Ltd. L

October 1st (Fri) 11:50~12:40(15th venue)PACIFICO Yokohama 5rd floor Room 501
Chair:Kazuto Nishio(Department of Genome Biology, Kindai University Faculty of Medicine)
Challenges and Prospects for Precision Medicine
Speaker:Masayuki Takeda(Department of Cancer Genomics and Medical Oncology, Nara Medical University)

LS24 ONO PHARMACEUTICAL CO., LTD. / Bristol-Myers Squibb K.K. L

October 1st (Fri) 11:50~12:40(16th venue)PACIFICO Yokohama 5rd floor Room 502
Chair:Kenzo Soejima(Clinical and Translational Research Center, Keio University Hospital)
Combined immunotherapy for advanced non-small cell lung cancer
Speaker 1:Isamu Okamoto(Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University)
CTLA-4 blockade in antitumor immunity
Speaker 2:Yosuke Togashi(Department of Tumor Microenvironment, Okayama University, Graduate School of Medicine Dentistry and Pharmaceutical Sciences)

LS25 Bayer Yakuhin, Ltd. L

October 1st (Fri) 11:50~12:40(17th venue)PACIFICO Yokohama 5rd floor Room 511+512
Chair:Hironobu Minami(Kobe University Graduate School of Medicine Oncology /Hematorogy)
Current status and future outlook of cancer precision medicine in Japan
– A new strategy for the treatment of gene fusion-positive solid tumors –
Speaker:Shinji Kohsaka(Division of Cellular Signaling National Cancer Center Research Institute)

October 2nd (Sat)

LS26 Janssen Pharmaceutical K.K. L

October 2nd(Sat) 11:50~12:40(Second venue)PACIFICO Yokohama 3rd floor Room 301
Chair:Koichi Akashi(Department of Medicine and Biosystemic Science, Graduate School of Medical Science, Kyushu University)
The fist-in-class anti-CD38 antibody daratumumab made a paradigm shift in the therapeutic landscape of multiple myeloma
Speaker:Yusuke Furukawa(Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University)

LS27 Merck Biopharma Co., Ltd.L

October 2nd(Sat) 11:50~12:40(Third venue)PACIFICO Yokohama 3rd floor Room 302
Chair:Junji Tsurutani (Advanced Cancer Translational research institute, Showa University)
Future Diagnostics for Precision Cancer Medicine; Genome x Pathology x AI = ?
Speaker:Hiroshi Nishihara (Genomics Unit, Keio Cancer Center, Keio University School of Medicine)

LS28 MSD K. K.L

October 2nd(Sat)11:50~12:40(4th venue)PACIFICO Yokohama 3rd floor Room 303
Chair:Seiji Yano(Division of Medical Oncology, Cancer Research Institute, Kanazawa University)
Recent advances in translational research for immune checkpoint inhibitors
Speaker:Shohei Koyama(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center / Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine)

LS29 10x Genomics Inc. / SCRUM Inc.L

October 2nd(Sat)11:50~12:40(5th venue)PACIFICO Yokohama 3rd floor Room 304
Chair:Yutaka Suzuki(Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo)
T cell clonal evolution in the tumor microenvironment elucidated by single-cell sequencing
Speaker:Yosuke Togashi(Department of Tumor Microenvironment, Okayama University, Graduate School of Medicine Dentistry and Pharmaceutical Sciences)

LS30 Janssen Pharmaceutical K.K. / NIPPON SHINYAKU CO., LTD. L

October 2nd(Sat) 11:50~12:40(7th venue)PACIFICO Yokohama 3rd floor Room 311+312
Chair:Kazutaka Saito(Dokkyo Medical University Saitama Medical Center)
Update on the treatment of metastatic prostate cancer based on mechanisms of therapeutic resistance
Speaker 1:Daisuke Obinata(Nihon University School of Medicine, Department of Urology)
Role of androgen receptor axis-targeted (ARAT) agents in diversifying prostate cancer treatments
Speaker 2:Kohei Hashimoto(Sapporo Medical University School of Medicine Department of urology)

LS31 Merck Biopharma Co., Ltd. / Pfizer Japan Inc.

October 2nd(Sat) 11:50~12:40(8th venue)PACIFICO Yokohama 3rd floor Room 313+314
Chair:Hideaki Miyake(Department of Urology, Hamamatsu University School of Medicine)
Cancer Immunotherapy in Urological Tumors
Speaker :Shigehisa Kitano(Division of Cancer Immunotherapy Development Advanced Medical Development Center)

LS32 CANON MEDICAL SYSTEMS CORPORATION.L

October 2nd(Sat) 11:50~12:40(9th venue)PACIFICO Yokohama 4rd floor Room 411+412
Chair:Manabu Muto(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
New initiatives for genomic medicine at Kyoto University Hospital
Speaker 1:Masashi Kanai(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University New initiatives for genomic medicine at Kyoto University Hospital)
Leveraging RWD can shift the future of cancer care.
Speaker 2:Shigemi Matsumoto(Department of Real World Data R & D, Graduate School of Medicine, Kyoto University)

LS33 AS ONE Corporation.O

October 2nd(Sat)11:50~12:40(11th venue)PACIFICO Yokohama 4rd floor Room 414+415
Chair:Naoto Momoda(AS ONE Corporation)
Introducing new spatial analysis technology: Quantitative image analysis by image-cytometry, and gene/protein-based hyperplex spatial profiling by index oligo-labeled probe.
Speaker:Takashi Matsui(AS ONE Corporation)